论文部分内容阅读
目的观察脑血疏口服液治疗高血压脑出血的临床疗效。方法收集我院2014年1月—2015年12月年神经外科住院病人85例。将85例高血压脑出血病人随机分为观察组43例和对照组42例。对照组仅给予常规治疗,观察组在常规治疗基础上给予脑血疏口服液,每次10mL,采用口服或鼻饲的方法,3次/日。比较两组入院时和治疗2周、4周的美国国立卫生研究院卒中量表(NIHSS)评分、格拉斯哥昏迷量表(GCS)评分、Barthel指数(BI)、血肿量的变化,评价脑血疏治疗高血压脑出血的效果。结果两组治疗前NIHSS评分、GCS评分、Barthel指数、血肿量差异无统计学意义(P>0.05);治疗第2周、第4周时,治疗组GCS评分、Barthel指数观察组明显高于对照组(P<0.05),NIHSS评分、脑出血血肿量明显低于对照组(P<0.05)。结论在常规内科治疗基础上联合应用脑血疏口服液能改善病人神经功能缺损症状,提高治愈率。
Objective To observe the clinical effect of Naoxuesu Oral Liquid on hypertensive intracerebral hemorrhage. Methods A total of 85 inpatients with neurosurgery in our hospital from January 2014 to December 2015 were collected. 85 patients with hypertensive intracerebral hemorrhage were randomly divided into observation group 43 cases and control group 42 cases. The control group was given only conventional treatment. The observation group was given NaoxueShu oral liquid on the basis of routine treatment, each time using 10mL oral or nasal feeding method, 3 times / day. The NIHSS score, Glasgow coma scale (GCS) score, Barthel index (BI), and hematoma volume were compared between the two groups on admission and for 2 weeks and 4 weeks of treatment. Treatment of hypertensive intracerebral hemorrhage effect. Results There was no significant difference in NIHSS, GCS, Barthel index and hematoma volume between the two groups before treatment (P> 0.05). GCS score and Barthel index in the second and fourth week of the treatment group were significantly higher than those of the control group (P <0.05). NIHSS score and hematoma volume of cerebral hemorrhage were significantly lower than those of control group (P <0.05). Conclusion In the conventional medical treatment based on the combination of Naoxuezhu oral liquid can improve the patient’s neurological deficit symptoms and improve the cure rate.